NCT03673124 · OUTCOME

ER Expression

Ribociclib and Letrozole Treatment in Ovarian Cancer · Source last updated 2025-12-23

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: At time of primary and secondary outcome analysis up to 5 years.

What was measured

Determine the expression of estrogen receptor (ER) and correlation with response and clinical benefit.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denom Units Selected: Participants
description: Determine the expression of estrogen receptor (ER) and correlation with response and clinical benefit.
reporting Status: NOT_POSTED
time Frame: At time of primary and secondary outcome analysis up to 5 years.
title: ER Expression
type: OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice